|
ATXN7L3 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 9.800400E-02 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
8.910200E-02 |
| Normal-vs-Stage2 |
1.108450E-01 |
| Normal-vs-Stage3 |
1.207750E-01 |
| Normal-vs-Stage4 |
5.755000E-01 |
| Stage1-vs-Stage2 |
5.977000E-01 |
| Stage1-vs-Stage3 |
9.620400E-01 |
| Stage1-vs-Stage4 |
2.867600E-01 |
| Stage2-vs-Stage3 |
6.011400E-01 |
| Stage2-vs-Stage4 |
2.541600E-01 |
| Stage3-vs-Stage4 |
3.495200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.528000E-02 |
| Normal-vs-AfricanAmerican |
5.867400E-01 |
| Normal-vs-Asian |
8.318100E-02 |
| Caucasian-vs-AfricanAmerican |
2.748100E-02 |
| Caucasian-vs-Asian |
8.375200E-03 |
| AfricanAmerican-vs-Asian |
2.102200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.575670E-02 |
| Normal-vs-Female |
9.192200E-01 |
| Male-vs-Female |
8.190300E-04 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.323600E-01 |
| Normal-vs-Age(41-60Yrs) |
1.810810E-01 |
| Normal-vs-Age(61-80Yrs) |
1.035240E-01 |
| Normal-vs-Age(81-100Yrs) |
2.183600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.211400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.069600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.227800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.000400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.492000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.202400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
1.194950E-01 |
| Normal-vs-Grade 2 |
1.101980E-01 |
| Normal-vs-Grade 3 |
8.278600E-03 |
| Normal-vs-Grade 4 |
5.583800E-01 |
| Grade 1-vs-Grade 2 |
1.480230E-02 |
| Grade 1-vs-Grade 3 |
1.295840E-03 |
| Grade 1-vs-Grade 4 |
2.181000E-01 |
| Grade 2-vs-Grade 3 |
2.126800E-01 |
| Grade 2-vs-Grade 4 |
1.849870E-02 |
| Grade 3-vs-Grade 4 |
5.221100E-04 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
2.177900E-02 |
| Normal-vs-ccB subtype |
1.658610E-01 |
| ccA subtype-vs-ccB subtype |
4.484200E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.625500E-02 |
| Normal-vs-N1 |
2.095200E-01 |
| N0-vs-N1 |
2.299600E-02 |
|
|
